DK168515B1 - Antidiuretisk middel - Google Patents

Antidiuretisk middel Download PDF

Info

Publication number
DK168515B1
DK168515B1 DK546284A DK546284A DK168515B1 DK 168515 B1 DK168515 B1 DK 168515B1 DK 546284 A DK546284 A DK 546284A DK 546284 A DK546284 A DK 546284A DK 168515 B1 DK168515 B1 DK 168515B1
Authority
DK
Denmark
Prior art keywords
ddavp
dose
agent
antidiuretic
deamino
Prior art date
Application number
DK546284A
Other languages
Danish (da)
English (en)
Other versions
DK546284D0 (da
DK546284A (da
Inventor
Helmer Hagstam
Hans Vilhardt
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20353381&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK168515(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of DK546284D0 publication Critical patent/DK546284D0/da
Publication of DK546284A publication Critical patent/DK546284A/da
Application granted granted Critical
Publication of DK168515B1 publication Critical patent/DK168515B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK546284A 1983-11-18 1984-11-16 Antidiuretisk middel DK168515B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8306367 1983-11-18
SE8306367A SE8306367L (sv) 1983-11-18 1983-11-18 Antidiuretiskt verkande farmaceutiskt preparat

Publications (3)

Publication Number Publication Date
DK546284D0 DK546284D0 (da) 1984-11-16
DK546284A DK546284A (da) 1985-05-19
DK168515B1 true DK168515B1 (da) 1994-04-11

Family

ID=20353381

Family Applications (1)

Application Number Title Priority Date Filing Date
DK546284A DK168515B1 (da) 1983-11-18 1984-11-16 Antidiuretisk middel

Country Status (19)

Country Link
US (1) US5047398A (xx)
EP (1) EP0163723B1 (xx)
KR (1) KR930003332B1 (xx)
AU (1) AU577338B2 (xx)
BE (1) BE901073A (xx)
CA (1) CA1232839A (xx)
DE (1) DE3482028D1 (xx)
DK (1) DK168515B1 (xx)
FI (1) FI844540L (xx)
IE (1) IE57989B1 (xx)
IL (1) IL73523A (xx)
IN (1) IN159607B (xx)
IT (1) IT1206233B (xx)
NZ (1) NZ210245A (xx)
OA (1) OA08164A (xx)
PT (1) PT79513B (xx)
SE (1) SE8306367L (xx)
WO (1) WO1985002119A1 (xx)
ZA (1) ZA848965B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988005661A1 (en) * 1987-01-30 1988-08-11 Biomed Research Consultants, Limited Vasopressin-based pharmaceutical compositions
US5350766A (en) * 1992-12-18 1994-09-27 New York Medical College Method for the prevention and/or palliation of the complications of diabetes using N-alpha orginine acetyl
SE9300937L (sv) * 1993-03-19 1994-09-20 Anne Fjellestad Paulsen Komposition för oral administrering av peptider
DK0710243T3 (da) * 1993-06-29 2000-10-16 Ferring Bv Syntese af cykliske peptider
US5500413A (en) * 1993-06-29 1996-03-19 Ferring Ab Process for manufacture of 1-deamino-8-D-arginine vasopressin
US5922680A (en) * 1996-10-23 1999-07-13 Ferring, B.V. Stabilized composition for oral administration of peptides
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US7094545B2 (en) * 2003-04-30 2006-08-22 Ferring Bv Pharmaceutical composition as solid dosage form and method for manufacturing thereof
ES2236640T3 (es) * 2003-04-30 2005-07-16 Ferring B.V. Forma posologica de la desmopresina.
PT1500390E (pt) * 2003-07-25 2005-10-31 Ferring Bv Composicao farmaceutica como forma de dosagem solida e metodo de producao
CN1826099B (zh) * 2003-07-25 2010-06-09 凡林有限公司 固体剂型药物组合物及其制造方法
DK1530967T3 (da) * 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
US7018653B2 (en) * 2003-12-29 2006-03-28 Ferring B.V. Method for preparing solid dosage form of desmopressin
SE0600482L (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2472539C2 (ru) 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
ES2319054B1 (es) 2007-08-06 2010-02-12 Gp Pharm S.A. Composicion farmaceutica oral de desmopresina.
EP3225249B1 (en) 2008-05-21 2018-11-07 Ferring B.V. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
CA2765221C (en) 2009-06-18 2017-10-03 Allergan, Inc. Safe desmopressin administration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH442342A (de) * 1964-07-17 1967-08-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
CH495957A (de) * 1966-09-15 1970-09-15 Ceskoslovenska Akademie Ved Verfahren zur Herstellung eines antidiuretisch wirksamen Polypeptids

Also Published As

Publication number Publication date
OA08164A (en) 1987-03-31
AU577338B2 (en) 1988-09-22
NZ210245A (en) 1989-02-24
FI844540A0 (fi) 1984-11-19
IE842951L (en) 1985-05-18
IT8409544A0 (it) 1984-11-19
KR930003332B1 (ko) 1993-04-26
US5047398A (en) 1991-09-10
EP0163723A1 (en) 1985-12-11
DE3482028D1 (de) 1990-05-31
DK546284D0 (da) 1984-11-16
SE8306367D0 (sv) 1983-11-18
CA1232839A (en) 1988-02-16
BE901073A (fr) 1985-03-15
IE57989B1 (en) 1993-06-02
KR850700109A (ko) 1985-10-25
AU3673484A (en) 1985-06-03
WO1985002119A1 (en) 1985-05-23
IL73523A0 (en) 1985-02-28
IT1206233B (it) 1989-04-14
SE8306367L (sv) 1985-05-19
DK546284A (da) 1985-05-19
FI844540L (fi) 1985-05-19
IN159607B (xx) 1987-05-30
EP0163723B1 (en) 1990-04-25
IL73523A (en) 1989-02-28
EP0163723A4 (en) 1986-04-02
PT79513A (en) 1984-12-01
PT79513B (en) 1986-11-18
ZA848965B (en) 1985-10-30

Similar Documents

Publication Publication Date Title
DK168515B1 (da) Antidiuretisk middel
Weiner et al. Hyperkalemia: a potential silent killer.
FORDTRAN et al. Sugar absorption tests, with special reference to 3-0-methyl-d-glucose and d-xylose
Caione et al. Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin
KOPPEL et al. Thiazide-lnduced Rise in Serum Calcium and Magnesium in Patients on Maintenance Hemodialysis
US7727959B2 (en) Use of substances with oxytocin activity against climacteric disorders
CZ286202B6 (cs) Farmaceutický přípravek
US5393531A (en) Process for the preparation of a pharmaceutical formulation containing at least two different active substances and use of such a formulation
CA2222770A1 (en) Method of treating rheumatoid arthritis with low dose type ii collagen
WO1984002470A1 (en) Medicinal preparation for the therapeutic treatment of peptic ulcer
SA00210092B1 (ar) تركيبة صيدلانية pharmaceutical formulation تشتمل على مثبط للثرومبين thrombin inhibitor منخفض الوزن الجزيئي low molecular weight
EP2598123A1 (en) Compositions
WO2020187017A1 (zh) 润肠通便的中药组合物、其制备方法及应用
AU2004320512A1 (en) Method of bowel cleansing
FI89240B (fi) Anvaendning av tillsatsmedel foer oekning av ibuprofens absorptionshastighet
JP2660333B2 (ja) 抗利尿剤
CN111603465A (zh) 洛伐他汀在制备治疗新冠肺炎药物中的应用
CN111588719A (zh) 辛伐他汀在制备治疗新冠肺炎药物中的应用
JPS6248622A (ja) 癌転移抑制剤
Conte et al. Renal function in chronic lithium‐treated patients
Meadow et al. Poisoning with delayed-release tablets: Treatment of Debendox poisoning with purgation and dialysis
RU2039566C1 (ru) Способ лечения воспалительных и дистрофических заболеваний слизистых оболочек органов пищеварения
EP1159959A1 (en) Preventive for respiratory infectious diseases
CN111617077A (zh) 氟伐他汀钠在制备治疗新冠肺炎药物中的应用
Connelly et al. Levofloxacin-induced bilateral Achilles tendinopathy

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired